About
Technology
Issues
FAQ
Links
Official Page
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.